DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Frazier Healthcare Partners
Frazier Healthcare Partners
Private equity with venture activity · probableSeattle, WAfrazierhealthcare.comSEC registered investment adviserone firm, 2 filing advisers
This firm files as 2 advisers on frazierhealthcare.com: Frazier Technology Ventures. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
With its purpose-driven culture and deep industry expertise, the Frazier Growth Buyout team is the preferred partner to profitable healthcare companies.
registered adviser; venture funds are 36% of 25 private funds
Importance
53
elevated
Active deployment
55
elevated
Emerging
0
low
Completeness
81
high
Freshness
100
high
Research priority
19
moderate
Identity and regulatory footprint
- Headquarters
- Seattle, WAadviserinfo.sec.gov
- Office address
- 601 UNION STREET, SUITE 3200, Seattle, WA, 98101adviserinfo.sec.gov
- Business phone
- 206-621-7200adviserinfo.sec.gov
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Jun 18, 2026
- Private funds reported
- 25 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $8.2Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $7.7Bthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 100
- Owners on Schedule A
- Alki Fund, Inc. (Member), C; BJM Washington Holdings LLC (Member), C; Desert Mountain LLC (Member), C
- business email
- ir@frazierhealthcare.comfrazierhealthcare.compublished by the subject
- business phone
- 206-621-7200adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
22 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, edtech, industrial
- Stages
- growth, early
- Geography
- chicago, globally, indiana, michigan, minnesota, new york, north carolina, seattle
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- growth investor
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 22
Funds and vehicles
5 reported, 8 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Frazier Healthcare Growth XI | Growth fund | 2025 lp reported | Early deployment | unknown | unknown | unknown | unknown |
| Frazier Healthcare VII, L.P. | Fund · ADV: Private Equity Fund | 2012 form d first sale | Harvest | $88.6M Mar 30, 2024 | 39 | $294M of $400M | Sep 30, 2013 |
| Frazier Healthcare Ventures V, L.P | Fund | 2005 lp reported | Harvest | unknown | unknown | unknown | unknown |
| Frazier Healthcare II, L.P | Fund | 1996 lp reported | Harvest | unknown | unknown | unknown | unknown |
| Frazier Healthcare VI, L.P. | Fund | unknown | Unknown | $73.7M Mar 30, 2024 | 56 | unknown | unknown |
| Frazier Healthcare VII (cayman), L.P. | Feeder or parallel · ADV: Private Equity Fund | 2015 adv first reported | Wound down | $118M Mar 30, 2020 | 38 | unknown | unknown |
| Frazier Healthcare Vii-A (cayman), L.P. | Feeder or parallel · ADV: Private Equity Fund | 2015 adv first reported | Wound down | $33.5M Mar 30, 2020 | 5 | unknown | unknown |
| Frazier Healthcare VI (cayman), L.P. | Feeder or parallel | 2015 adv first reported | Wound down | $0 Mar 30, 2020 | 59 | unknown | unknown |
| Frazier Healthcare V, L.P. | Fund | unknown | Wound down | $173M Nov 2, 2021 | 57 | unknown | unknown |
| Frazier Healthcare IV, L.P. | Fund | unknown | Wound down | $52.5M Mar 29, 2019 | 80 | unknown | unknown |
| Frazier Healthcare III, L.P. | Fund | unknown | Wound down | $2.6M May 17, 2017 | 56 | unknown | unknown |
| Frazier Affiliates IV, L.P. | Feeder or parallel | unknown | Wound down | $265,092 Mar 29, 2019 | 38 | unknown | unknown |
| Frazier Affiliates III, L.P. | Feeder or parallel | unknown | Wound down | $18,871 May 17, 2017 | 23 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
113 current, 5 departed
Adam Rubinger
AssociateAssociate
Alex Adams
AssociateAssociate
Gavin Calabretta
AssociateAssociate
Jafar Sharipov
AssociateAssociate
John Froman
AssociateAssociate
Maggie Mckay
AssociateAssociate
Nathan Marks
AssociateAssociate
Barbara Wachsman
Board or advisorySenior Advisor
Bill Mitchell
Board or advisorySenior Advisor
Craig Goguen
Board or advisorySenior Advisor
Eric Palmer
Board or advisorySenior Advisor
Faisal Mushtaq
Board or advisorySenior Advisor
Frank Segrave
Board or advisorySenior Advisor
Jim Brady
Board or advisorySenior Advisor
Michael O'Boyle
Board or advisorySenior Advisor
Mikey Kindler
Board or advisorySenior Advisor
Rob Kill
Board or advisorySenior Advisor
Roger Davis
Board or advisorySenior Advisor
Scott Walker
Board or advisorySenior Advisor
Susan Weaver
Board or advisorySenior Advisor
Alan Frazier
Founder or executiveFounder & Senior Advisor
Brian Morfitt
General partnerGeneral Partner · since Jan 1, 2016
Brian Morfitt
General partnerGeneral Partner
Christina Reszka
General partnerGeneral Partner
Nathan Every
General partnerGeneral Partner
Philip Zaorski
General partnerGeneral Partner
Ryan Lucero
General partnerGeneral Partner
Year Joined
General partnerBrian Morfitt - General Partner
Carol Eckert
Investor relationsSenior Vice President of Investor Relations
Peter Tornatore
Investor relationsPrincipal of Investor Relations
Ben Magnano
Managing partnerManaging Partner
Nader Jafari Naini
Managing partnerManaging Partner · since Jun 1, 1992
Nader Naini
Managing partnerManaging Partner
California Lutheran University (MBA)
OtherWes Wheeler - Executive in Residence
David Kosloff
OtherExecutive in Residence
Investor Relations
OtherGrowth Buyout Investment Professionals
Maria Molland
OtherExecutive in Residence
Milton Boyer
OtherExecutive in Residence
Steve Krupa
OtherExecutive in Residence
Wes Wheeler
OtherExecutive in Residence
Anthony Draye
PartnerCoE - Partner, Technology & Innovation
Ben Magnano
PartnerSole Shareholder · since Jan 1, 2021
Caitlin Walker
PartnerCoE - Partner, Human Capital
Cornell University (MBA)
PartnerMichael Miraflores - CoE - Partner, Mergers & Acquisitions
Douglas Hollenbeck
PartnerPartner
Hannah Lynch
PartnerSenior Tax Manager
Jamie Hemsell
PartnerBusiness Support Manager
John Payton
PartnerSenior Manager, Portfolio Valuation & Analytics
Kent Berkley
PartnerPartner
Lynne Partridge
PartnerAdministration Manager
Michael Miraflores
PartnerCoE - Partner, Mergers & Acquisitions
Nathan R Every
PartnerSole Shareholder · since Jan 1, 2021
Priti Shah
PartnerCoE - Partner, Product Excellence
Tanya Hayes
PartnerCoE - Partner, Human Capital
Andy Caine
Platform and operationsCoE - COO and Partner
Ben Hansen
Platform and operationsCoE - Partner, Finance & Operations
Boston University (LLM)
Platform and operationsRick Maroun - CoE - General Counsel and Partner, Legal & Operations
Brad Alexander
Platform and operationsCoE - Partner, Finance & Operations
Bradd Busick
Platform and operationsCoE - Principal, Data Analytics & Artificial Intelligence
Brown University (MS)
Platform and operationsBradd Busick - CoE - Principal, Data Analytics & Artificial Intelligence
Corina Catapano
Platform and operationsExecutive Assistant & Project Manager
Cornell University (BA)
Platform and operationsJessica Jacobs - CoE - Vice President, Legal
Debra Chrisman
Platform and operationsAssistant Controller
Jenna Braden
Platform and operationsExecutive Assistant
Jessica Jacobs
Platform and operationsCoE - Vice President, Legal
Jin On
Platform and operationsCoE - Vice President, Data Science & Artificial Intelligence
Joe Whitters
Platform and operationsCoE - Partner, Finance & Operations
Katie Reynolds
Platform and operationsExecutive Assistant
Kelly Hoagland
Platform and operationsExecutive Assistant
Ken McLaren
Platform and operationsCoE - Partner, Data & Artificial Intelligence
Luther College (BA)
Platform and operationsJoe Whitters - CoE - Partner, Finance & Operations
Maggie Lee
Platform and operationsBusiness Support Coordinator & Executive Assistant
Morgan Finch
Platform and operationsExecutive Assistant
Nicole Sands
Platform and operationsCoE - Principal, Commercial Strategy & Marketing
Nicole Shannon
Platform and operationsFund Accounting Manager
Omnya El Massad
Platform and operationsCoE - Director, Data & Artificial Intelligence
Rebekah Worley
Platform and operationsExecutive Assistant & Accounting Support
Rick Maroun
Platform and operationsCoE - General Counsel and Partner, Legal & Operations
Sanji Fernando
Platform and operationsCoE - Partner, Data Analytics & Artificial Intelligence
Steve Bailey
Platform and operationsCFO, CCO & Partner
Steve Ray Bailey
Platform and operationsChief Financial Officer & Chief Compliance Officer · since Jun 1, 2003
Steve Tallman
Platform and operationsCoE - Partner, Finance & Operations
Sydnie Heberling
Platform and operationsVice President of Finance
Tyler Menk
Platform and operationsFund Accounting Manager
Clarissa Berman
PrincipalPrincipal
Jay Lofton
PrincipalCoE - Director, Financial Planning & Analysis
Jeremy Janson
PrincipalPrincipal
Kevin Chinn
PrincipalCoE - Principal, Sales Excellence
Liza Langston
PrincipalCoE - Director, Deal Origination
Shyamal Swami
PrincipalPrincipal
Souvick Paul
PrincipalCoE - Principal, Technology & Innovation
Steve Blackhart
PrincipalCoE - Principal, Corporate Development
Adam Keim
Vice presidentCoE - Vice President, Technology & Innovation
Alex Saunders
Vice presidentSenior Associate
Andrew Wu
Vice presidentVice President
Charles Nenichka
Vice presidentSenior Associate
Daniel Ewnetu
Vice presidentSenior Associate
Ellie Coleman
Vice presidentCoE - Vice President, Human Capital
Emily Terry
Vice presidentCoE - Vice President, Human Capital
Hannah Maatallah
Vice presidentVice President
Harish Venkata
Vice presidentCoE - Vice President, Cybersecurity & Enterprise Risk Management
Ilene Cheung
Vice presidentSenior Associate
Jack Trunzo
Vice presidentVice President
James Thompson
Vice presidentSenior Associate
Jennifer Zhuang
Vice presidentVice President
Laura Edwards
Vice presidentCoE - Vice President, Human Capital & ESG
Laura Tang
Vice presidentSenior Associate
Luke Ostrander
Vice presidentSenior Associate
Matt Hinshaw
Vice presidentVice President
Michael Machak
Vice presidentVice President
Mike Gawlik
Vice presidentVice President
Reema Asad
Vice presidentCoE - Vice President, Technology & Project Management
Renee Olson
Vice presidentVice President of Human Resources
5 departed (kept with end dates)
- Alan David Frazier · Shareholder · Aug 1, 1991 to Mar 31, 2021 Inference
- Alan David Frazier · Sole Shareholder · Aug 1, 1991 to Mar 29, 2016 Inference
- James Topper · Member · Apr 1, 2013 to Mar 31, 2022 Inference
- Patrick Heron · Member · Apr 1, 2014 to Mar 31, 2022 Inference
- Thomas Scott Hodge · Chief Operating Officer · Jul 1, 2000 to Mar 31, 2014 Inference
Investments on record
22 edges, 22 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
8 relationships from shared deals, counted for the whole firm
MK Capital Company 1 shared · one timeRevelation Partners 1 shared · one time · they led 1Civilization Ventures Management, LLC 1 shared · one timeLYFE Capital 1 shared · one time · they led 1Life Sciences 1 shared · one timeNelstone Ventures Advisors 1 shared · one timeEducation Growth Partners, LLC 1 shared · one timeVoyager Partners Management LLC 1 shared · one time
Limited partners
6 disclosed
- Washington State Investment Board $40.0M sib.wa.gov
- California State Teachers' Retirement System $47.5M calstrs.com
- Washington State Investment Board in Frazier Healthcare II, L.P $10.0M sib.wa.gov
- Washington State Investment Board in Frazier Healthcare IV, L.P. $40.0M sib.wa.gov
- California State Teachers' Retirement System in Frazier Healthcare Growth XI $100M calstrs.com
- California State Teachers' Retirement System in Frazier Healthcare Ventures V, L.P $47.5M calstrs.com
Timeline
48 dated events
- Sep 16, 2026ClinOne no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceClinOneVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Apex Learning no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceApex LearningVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Matrix Medical Network no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceMatrix Medical NetworkVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Contractpharma no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceContractpharmaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Cpspharm no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceCpspharmVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Presspubs no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferencePresspubsVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Beloit no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferenceBeloitVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Psychcongress no longer listed on Frazier Healthcare Partners's portfolio pageRemoved from portfolio pagePortfolioInferencePsychcongressVenture organization websites (about, team, portfolio, thesis, news pages)
- Dec 31, 2025WSIB reports Frazier Healthcare IV, L.P.: $40,000,000 committed, vintage 2001, net IRR 0.7%, 1.0x
- Dec 31, 2025WSIB reports Frazier Healthcare II, L.P.: $10,000,000 committed, vintage 1996, net IRR 6.9%, 1.5x
- Jun 30, 2025CalSTRS reports Frazier Healthcare Ventures V, L.P.: $47,473,830 committed, vintage 2005, net IRR 14.7%, 2.28x
- Jun 30, 2025CalSTRS reports Frazier Healthcare Growth XI: $100,000,000 committed, vintage 2025
- Mar 31, 2022Frazier Life Sciences X, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Life Sciences X, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2022Frazier Healthcare V, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Healthcare V, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2022James Newman Topper (Member) no longer on Schedule A of Frazier Healthcare Partners
- Mar 31, 2022Frazier Life Sciences Viii, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Life Sciences Viii, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2022Frazier Life Sciences Ix, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Life Sciences Ix, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2022Patrick James Heron (Member) no longer on Schedule A of Frazier Healthcare Partners
- Mar 31, 2021Frazier Healthcare VI (cayman), L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Healthcare VI (cayman), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Frazier Healthcare VII (cayman) , L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Healthcare VII (cayman), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Frazier Healthcare Vii-A (cayman), L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Healthcare Vii-A (cayman), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2021Alan David Frazier (Shareholder) no longer on Schedule A of Frazier Healthcare Partners
- Mar 30, 2020Frazier Affiliates IV, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Affiliates IV, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2020Frazier Life Sciences X, L.P. first reported on Form ADV by Frazier Healthcare Partners (Venture Capital Fund), GAV $617,050,000Fund first reported on Form ADVFundsFactFrazier Life Sciences X, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2020Frazier Healthcare IV, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Healthcare IV, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2018Frazier Healthcare III, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Healthcare III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2018Frazier Affiliates III, L.P. no longer reported on Form ADV by Frazier Healthcare PartnersFund no longer reportedFundsInferenceFrazier Affiliates III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2018Frazier Life Sciences Ix, L.P. first reported on Form ADV by Frazier Healthcare Partners (Venture Capital Fund), GAV $418,925,000Fund first reported on Form ADVFundsFactFrazier Life Sciences Ix, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2016Frazier Life Sciences Viii, L.P. first reported on Form ADV by Frazier Healthcare (Venture Capital Fund), GAV $262,000,000Fund first reported on Form ADVFundsFactFrazier Life Sciences Viii, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 1, 2016BEN Magnano joined Schedule A of Frazier Healthcare as Member
- Jan 1, 2016Brian Morfitt joined Schedule A of Frazier Healthcare as Member
- Mar 13, 2015Frazier Healthcare Vii-A (cayman), L.P. first reported on Form ADV by Frazier Healthcare (Venture Capital Fund), GAV $7,386,624Fund first reported on Form ADVFundsFactFrazier Healthcare Vii-A (cayman), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 13, 2015Frazier Healthcare VII (cayman) , L.P. first reported on Form ADV by Frazier Healthcare (Venture Capital Fund), GAV $25,920,588Fund first reported on Form ADVFundsFactFrazier Healthcare VII (cayman), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 13, 2015Frazier Healthcare VI (cayman), L.P. first reported on Form ADV by Frazier Healthcare (Venture Capital Fund), GAV $148,863,385Fund first reported on Form ADVFundsFactFrazier Healthcare VI (cayman), L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 1, 2014Nathan R Every joined Schedule A of Frazier Healthcare as Member
- Apr 1, 2014Patrick Heron joined Schedule A of Frazier Healthcare as Member
- Mar 31, 2014Frazier Healthcare VII, L.P. first reported on Form ADV by Frazier Healthcare (Venture Capital Fund), GAV $4,908,773Fund first reported on Form ADVFundsFactFrazier Healthcare VII, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2014Frazier Healthcare Vii-A, L.P. first reported on Form ADV by Frazier Healthcare (Venture Capital Fund), GAV $1,004,621Fund first reported on Form ADVFundsFactFrazier Healthcare Vii-A, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2014Thomas Scott Hodge (Chief Operating Officer) no longer on Schedule A of Frazier Healthcare
- Apr 1, 2013James Topper joined Schedule A of Frazier Healthcare as Member
- Mar 30, 2012Frazier Affiliates III, L.P. first reported on Form ADV by Frazier Management, L.L.C. (Venture Capital Fund), GAV $239,527Fund first reported on Form ADVFundsFactFrazier Affiliates III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Frazier Affiliates IV, L.P. first reported on Form ADV by Frazier Management, L.L.C. (Venture Capital Fund), GAV $756,498Fund first reported on Form ADVFundsFactFrazier Affiliates IV, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Frazier Management, L.L.C. first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Frazier Healthcare IV, L.P. first reported on Form ADV by Frazier Management, L.L.C. (Venture Capital Fund), GAV $147,865,885Fund first reported on Form ADVFundsFactFrazier Healthcare IV, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Frazier Healthcare V, L.P. first reported on Form ADV by Frazier Management, L.L.C. (Venture Capital Fund), GAV $359,876,961Fund first reported on Form ADVFundsFactFrazier Healthcare V, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Frazier Healthcare III, L.P. first reported on Form ADV by Frazier Management, L.L.C. (Venture Capital Fund), GAV $29,002,550Fund first reported on Form ADVFundsFactFrazier Healthcare III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Frazier Healthcare VI, L.P. first reported on Form ADV by Frazier Management, L.L.C. (Venture Capital Fund), GAV $257,287,724Fund first reported on Form ADVFundsFactFrazier Healthcare VI, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 1, 1991Alan David Frazier joined Schedule A of Frazier Healthcare as Shareholder
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 36% of 25 private funds
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 36% of 17 private funds
Evidence
69 observations from 3 sources